Contact Us
Drug Search Results
More Filters [+]

Nitazoxanide

Alternative Names: nitazoxanide, alinia
Latest Update: 2024-11-19
Latest Update Note: Clinical Trial Update

Product Description

Nitazoxanide is a first-line choice for the treatment of illness caused by C. parvum or G. lamblia infection in immunocompetent adults and children, and is an option to be considered in the treatment of illnesses caused by other protozoa and/or helminths. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/17722965/)

Mechanisms of Action: Wnt Inhibitor,Autophagy Stimulant,mTOR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | Brazil | Chile | Colombia | Dominican Republic | Ecuador | Egypt | Greece | India | Italy | Mexico | Pakistan | Peru | Slovenia | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Romark
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nitazoxanide

Countries in Clinic: United States

Active Clinical Trial Count: 2

Highest Development Phases

Phase 1: Healthy Volunteers|Kidney Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
NTZ-122-1

P1

Completed

Kidney Diseases

2022-09-04

21%
NTZ-121-1

P1

Completed

Healthy Volunteers

2022-04-08

28%

Recent News Events

Date

Type

Title

11/13/2024

News Article

 GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

05/29/2024

News Article

 GENFIT to Present Latest ACLF Research at EASL Congress™ 2024

10/19/2023

News Article

 Alinia (nitazoxanide) Market 2023 Industry Size, Shares, Segment and Forecast up to 2032

09/20/2023

News Article

 GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions